Trial Profile
A randomised trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Nov 2012 New trial record